Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Surgical Flaps | 12 | 2024 | 1640 | 1.470 |
Why?
|
Hand Injuries | 4 | 2019 | 242 | 1.210 |
Why?
|
Fees, Medical | 1 | 2023 | 117 | 0.890 |
Why?
|
Surgery, Plastic | 4 | 2016 | 624 | 0.830 |
Why?
|
Range of Motion, Articular | 3 | 2019 | 1578 | 0.770 |
Why?
|
Perineum | 2 | 2024 | 211 | 0.720 |
Why?
|
Anus Neoplasms | 1 | 2024 | 332 | 0.710 |
Why?
|
Therapies, Investigational | 2 | 2019 | 112 | 0.710 |
Why?
|
Graft Rejection | 9 | 2020 | 4397 | 0.680 |
Why?
|
Role | 1 | 2019 | 175 | 0.680 |
Why?
|
Sus scrofa | 1 | 2020 | 437 | 0.670 |
Why?
|
Finger Phalanges | 1 | 2019 | 38 | 0.670 |
Why?
|
Limb Salvage | 2 | 2021 | 433 | 0.650 |
Why?
|
Arm | 3 | 2020 | 589 | 0.640 |
Why?
|
Metacarpal Bones | 1 | 2019 | 73 | 0.640 |
Why?
|
Organ Transplantation | 3 | 2024 | 1139 | 0.610 |
Why?
|
Hand | 4 | 2021 | 884 | 0.600 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2016 | 50 | 0.580 |
Why?
|
Facial Transplantation | 5 | 2020 | 226 | 0.570 |
Why?
|
Arthroplasty, Replacement, Knee | 4 | 2021 | 1458 | 0.560 |
Why?
|
Carcinoma, Squamous Cell | 10 | 2016 | 4034 | 0.560 |
Why?
|
Femoral Artery | 1 | 2020 | 845 | 0.550 |
Why?
|
Free Tissue Flaps | 4 | 2015 | 328 | 0.540 |
Why?
|
Upper Extremity | 4 | 2023 | 648 | 0.530 |
Why?
|
Medical Tourism | 1 | 2016 | 57 | 0.520 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2016 | 417 | 0.520 |
Why?
|
Rectal Neoplasms | 1 | 2024 | 1206 | 0.490 |
Why?
|
Burnout, Professional | 2 | 2020 | 694 | 0.480 |
Why?
|
Tibia | 2 | 2019 | 1077 | 0.470 |
Why?
|
Recovery of Function | 4 | 2017 | 2925 | 0.450 |
Why?
|
Skin Transplantation | 5 | 2022 | 1074 | 0.450 |
Why?
|
Surgical Wound Dehiscence | 1 | 2014 | 215 | 0.450 |
Why?
|
Chlorhexidine | 1 | 2014 | 162 | 0.440 |
Why?
|
Hand Strength | 1 | 2016 | 448 | 0.430 |
Why?
|
Knee Joint | 3 | 2021 | 1680 | 0.410 |
Why?
|
Osteochondroma | 1 | 2012 | 47 | 0.410 |
Why?
|
Anti-Infective Agents, Local | 1 | 2014 | 250 | 0.410 |
Why?
|
Tibial Fractures | 1 | 2014 | 269 | 0.400 |
Why?
|
Extremities | 1 | 2017 | 865 | 0.400 |
Why?
|
Seasons | 1 | 2017 | 1493 | 0.400 |
Why?
|
Catheter-Related Infections | 1 | 2014 | 252 | 0.390 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2011 | 105 | 0.390 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2016 | 477 | 0.390 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2014 | 280 | 0.380 |
Why?
|
Osteomyelitis | 1 | 2014 | 402 | 0.370 |
Why?
|
First Aid | 1 | 2010 | 65 | 0.360 |
Why?
|
Microsurgery | 4 | 2018 | 796 | 0.360 |
Why?
|
Exercise Therapy | 1 | 2017 | 906 | 0.360 |
Why?
|
Cost of Illness | 1 | 2019 | 1859 | 0.350 |
Why?
|
Compartment Syndromes | 1 | 2011 | 153 | 0.350 |
Why?
|
Sepsis | 1 | 2024 | 2593 | 0.350 |
Why?
|
Hypothermia | 1 | 2010 | 189 | 0.340 |
Why?
|
Hyperemia | 1 | 2010 | 225 | 0.330 |
Why?
|
Fingers | 1 | 2012 | 513 | 0.330 |
Why?
|
Abdominal Fat | 1 | 2010 | 223 | 0.330 |
Why?
|
Antigens, CD1 | 2 | 2021 | 437 | 0.320 |
Why?
|
Laparotomy | 1 | 2010 | 473 | 0.320 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1941 | 0.310 |
Why?
|
Fracture Fixation, Internal | 1 | 2014 | 917 | 0.310 |
Why?
|
Physicians | 3 | 2023 | 4567 | 0.310 |
Why?
|
Caregivers | 1 | 2019 | 2094 | 0.310 |
Why?
|
Surgical Staplers | 1 | 2007 | 34 | 0.310 |
Why?
|
Craniosynostoses | 1 | 2012 | 401 | 0.300 |
Why?
|
Esophagoplasty | 1 | 2007 | 43 | 0.300 |
Why?
|
Oncogenes | 4 | 2008 | 1265 | 0.300 |
Why?
|
Fractures, Bone | 1 | 2019 | 1947 | 0.290 |
Why?
|
Burns | 3 | 2017 | 1815 | 0.290 |
Why?
|
Orthopedics | 1 | 2016 | 904 | 0.290 |
Why?
|
Quality of Life | 6 | 2023 | 12804 | 0.280 |
Why?
|
Soft Tissue Neoplasms | 2 | 2008 | 1363 | 0.280 |
Why?
|
Humans | 82 | 2024 | 744343 | 0.280 |
Why?
|
General Surgery | 2 | 2016 | 1636 | 0.270 |
Why?
|
Streptococcal Infections | 1 | 2010 | 638 | 0.270 |
Why?
|
Osteoarthritis, Knee | 3 | 2021 | 1222 | 0.270 |
Why?
|
Medicare | 1 | 2023 | 6566 | 0.260 |
Why?
|
Decompression, Surgical | 1 | 2010 | 594 | 0.260 |
Why?
|
Cardiopulmonary Bypass | 1 | 2010 | 1066 | 0.260 |
Why?
|
Surgical Wound Infection | 1 | 2014 | 1540 | 0.260 |
Why?
|
Jejunum | 1 | 2007 | 480 | 0.260 |
Why?
|
Graft Survival | 5 | 2019 | 3737 | 0.250 |
Why?
|
Postoperative Complications | 8 | 2024 | 15295 | 0.250 |
Why?
|
Internet | 1 | 2017 | 3064 | 0.250 |
Why?
|
Papillomavirus Infections | 1 | 2016 | 1587 | 0.250 |
Why?
|
Pharynx | 1 | 2007 | 413 | 0.250 |
Why?
|
Nerve Regeneration | 3 | 2020 | 788 | 0.250 |
Why?
|
Referral and Consultation | 1 | 2017 | 3528 | 0.240 |
Why?
|
Bacteremia | 1 | 2010 | 962 | 0.230 |
Why?
|
Postoperative Care | 3 | 2016 | 1486 | 0.230 |
Why?
|
Amputees | 2 | 2014 | 75 | 0.230 |
Why?
|
Gene Amplification | 2 | 2006 | 1063 | 0.230 |
Why?
|
Artificial Limbs | 2 | 2021 | 123 | 0.210 |
Why?
|
Fund Raising | 1 | 2022 | 47 | 0.200 |
Why?
|
Mycosis Fungoides | 1 | 2023 | 163 | 0.200 |
Why?
|
Skull Neoplasms | 2 | 2015 | 173 | 0.200 |
Why?
|
Tissue Donors | 4 | 2020 | 2240 | 0.190 |
Why?
|
Tissue and Organ Harvesting | 2 | 2017 | 369 | 0.190 |
Why?
|
Follow-Up Studies | 13 | 2019 | 39050 | 0.190 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2019 | 3508 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3158 | 0.190 |
Why?
|
Skin | 3 | 2022 | 4364 | 0.190 |
Why?
|
Male | 43 | 2021 | 350118 | 0.190 |
Why?
|
Heart Arrest | 1 | 2010 | 1470 | 0.190 |
Why?
|
Sciatic Nerve | 2 | 2020 | 607 | 0.180 |
Why?
|
Membrane Lipids | 1 | 2021 | 248 | 0.180 |
Why?
|
Carcinoma, Basal Cell | 2 | 2007 | 545 | 0.170 |
Why?
|
Wounds and Injuries | 1 | 2012 | 2400 | 0.170 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2529 | 0.170 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2019 | 134 | 0.170 |
Why?
|
Pelvis | 1 | 2024 | 730 | 0.170 |
Why?
|
Moral Obligations | 1 | 2020 | 96 | 0.170 |
Why?
|
Neoplasm, Residual | 1 | 2004 | 973 | 0.170 |
Why?
|
Treatment Outcome | 13 | 2021 | 63114 | 0.170 |
Why?
|
Health Services Accessibility | 1 | 2016 | 5137 | 0.160 |
Why?
|
Adipose Tissue | 1 | 2010 | 3279 | 0.160 |
Why?
|
Allyl Compounds | 2 | 2009 | 23 | 0.160 |
Why?
|
Transplantation, Homologous | 3 | 2024 | 4776 | 0.160 |
Why?
|
Immunosuppressive Agents | 5 | 2022 | 4149 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2009 | 8428 | 0.160 |
Why?
|
Wound Healing | 2 | 2023 | 2785 | 0.160 |
Why?
|
Proprioception | 1 | 2019 | 132 | 0.160 |
Why?
|
Female | 40 | 2022 | 380194 | 0.160 |
Why?
|
Drainage | 2 | 2016 | 1142 | 0.150 |
Why?
|
Aged | 23 | 2023 | 163280 | 0.150 |
Why?
|
Chemokines | 1 | 2022 | 970 | 0.150 |
Why?
|
Neovascularization, Pathologic | 2 | 2007 | 2635 | 0.150 |
Why?
|
Adult | 27 | 2020 | 214055 | 0.150 |
Why?
|
Isoantigens | 1 | 2019 | 567 | 0.150 |
Why?
|
Fracture Fixation | 1 | 2019 | 354 | 0.140 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5686 | 0.140 |
Why?
|
HLA Antigens | 2 | 2019 | 1381 | 0.140 |
Why?
|
Sarcoma | 1 | 2008 | 1897 | 0.140 |
Why?
|
Middle Aged | 26 | 2021 | 213383 | 0.140 |
Why?
|
Disulfides | 2 | 2009 | 457 | 0.130 |
Why?
|
Femur | 2 | 2019 | 1297 | 0.130 |
Why?
|
Arm Injuries | 1 | 2017 | 160 | 0.130 |
Why?
|
Isoantibodies | 1 | 2019 | 679 | 0.130 |
Why?
|
Thigh | 1 | 2016 | 247 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2021 | 2540 | 0.130 |
Why?
|
Boston | 3 | 2017 | 9313 | 0.130 |
Why?
|
Facial Injuries | 2 | 2013 | 183 | 0.120 |
Why?
|
Cyclin D1 | 1 | 2016 | 463 | 0.120 |
Why?
|
Biocompatible Materials | 1 | 2023 | 1736 | 0.120 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 642 | 0.120 |
Why?
|
Debridement | 2 | 2014 | 492 | 0.120 |
Why?
|
Electromyography | 1 | 2019 | 1379 | 0.120 |
Why?
|
Lung Neoplasms | 6 | 2008 | 13102 | 0.120 |
Why?
|
Retrospective Studies | 10 | 2024 | 77449 | 0.120 |
Why?
|
Rabbits | 2 | 2019 | 4894 | 0.120 |
Why?
|
Career Mobility | 1 | 2016 | 262 | 0.120 |
Why?
|
Oncogene Proteins | 2 | 2008 | 749 | 0.110 |
Why?
|
Self Efficacy | 1 | 2017 | 616 | 0.110 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10180 | 0.110 |
Why?
|
Explosions | 1 | 2013 | 109 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2020 | 1547 | 0.110 |
Why?
|
Certification | 1 | 2016 | 424 | 0.110 |
Why?
|
Prosthesis Design | 1 | 2019 | 2110 | 0.110 |
Why?
|
United States | 7 | 2023 | 69872 | 0.110 |
Why?
|
Bandages | 1 | 2014 | 266 | 0.110 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 890 | 0.110 |
Why?
|
Surgery Department, Hospital | 1 | 2013 | 175 | 0.100 |
Why?
|
Weight-Bearing | 1 | 2014 | 515 | 0.100 |
Why?
|
Sex Distribution | 1 | 2017 | 2297 | 0.100 |
Why?
|
Activities of Daily Living | 2 | 2020 | 2418 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1907 | 0.100 |
Why?
|
Accidents, Traffic | 1 | 2017 | 819 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2020 | 18029 | 0.100 |
Why?
|
Young Adult | 7 | 2019 | 56430 | 0.100 |
Why?
|
Age Distribution | 1 | 2017 | 2902 | 0.100 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2019 | 2015 | 0.100 |
Why?
|
Terrorism | 1 | 2013 | 211 | 0.100 |
Why?
|
Leeching | 1 | 2010 | 6 | 0.090 |
Why?
|
Trauma Centers | 1 | 2016 | 890 | 0.090 |
Why?
|
Leg | 2 | 2013 | 1116 | 0.090 |
Why?
|
Papillomaviridae | 1 | 2016 | 1119 | 0.090 |
Why?
|
Swine | 1 | 2020 | 5917 | 0.090 |
Why?
|
Buttocks | 1 | 2010 | 110 | 0.090 |
Why?
|
Lip | 1 | 2012 | 195 | 0.090 |
Why?
|
Blast Injuries | 1 | 2013 | 302 | 0.090 |
Why?
|
Tissue Transplantation | 1 | 2010 | 130 | 0.090 |
Why?
|
Steroids | 1 | 2015 | 930 | 0.090 |
Why?
|
Survival Rate | 3 | 2016 | 12788 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2014 | 1850 | 0.090 |
Why?
|
K562 Cells | 2 | 2021 | 634 | 0.090 |
Why?
|
Lipectomy | 1 | 2010 | 118 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2016 | 2924 | 0.080 |
Why?
|
Cosmetic Techniques | 1 | 2010 | 135 | 0.080 |
Why?
|
Gene Expression Profiling | 5 | 2009 | 9438 | 0.080 |
Why?
|
Prognosis | 8 | 2019 | 29063 | 0.080 |
Why?
|
Patient Admission | 1 | 2016 | 1380 | 0.080 |
Why?
|
Disability Evaluation | 1 | 2016 | 1827 | 0.080 |
Why?
|
Neoplasm Staging | 2 | 2016 | 11031 | 0.080 |
Why?
|
Time Factors | 4 | 2017 | 40075 | 0.080 |
Why?
|
Catechin | 1 | 2008 | 66 | 0.080 |
Why?
|
Orbital Fractures | 1 | 2009 | 110 | 0.080 |
Why?
|
Acetylcholinesterase | 1 | 2008 | 153 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2219 | 0.080 |
Why?
|
Leg Injuries | 1 | 2009 | 178 | 0.080 |
Why?
|
Disaster Planning | 1 | 2013 | 549 | 0.080 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1076 | 0.080 |
Why?
|
Veins | 1 | 2011 | 770 | 0.070 |
Why?
|
Tongue Neoplasms | 1 | 2009 | 180 | 0.070 |
Why?
|
Tonsillar Neoplasms | 1 | 2007 | 51 | 0.070 |
Why?
|
Muscle, Skeletal | 2 | 2019 | 4931 | 0.070 |
Why?
|
Income | 1 | 2016 | 1913 | 0.070 |
Why?
|
Pharyngeal Neoplasms | 1 | 2007 | 117 | 0.070 |
Why?
|
Bone Transplantation | 1 | 2012 | 907 | 0.070 |
Why?
|
Sesquiterpenes | 1 | 2008 | 177 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.070 |
Why?
|
Abscess | 1 | 2010 | 607 | 0.070 |
Why?
|
Bronchial Fistula | 1 | 2007 | 85 | 0.070 |
Why?
|
Patient Compliance | 1 | 2017 | 2684 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2759 | 0.070 |
Why?
|
Osteotomy | 1 | 2012 | 822 | 0.070 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 472 | 0.070 |
Why?
|
Cholinesterase Inhibitors | 1 | 2008 | 238 | 0.070 |
Why?
|
Multiple Trauma | 1 | 2009 | 367 | 0.070 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2023 | 4266 | 0.070 |
Why?
|
Pleural Diseases | 1 | 2007 | 139 | 0.070 |
Why?
|
Embolization, Therapeutic | 1 | 2015 | 1392 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8340 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2124 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 5221 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4042 | 0.060 |
Why?
|
Oculomotor Muscles | 1 | 2009 | 371 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 7181 | 0.060 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 376 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2009 | 3920 | 0.060 |
Why?
|
Ileum | 1 | 2007 | 565 | 0.060 |
Why?
|
Carcinoma, Basosquamous | 1 | 2004 | 7 | 0.060 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2004 | 91 | 0.060 |
Why?
|
Adrenocortical Adenoma | 1 | 2004 | 48 | 0.060 |
Why?
|
Complement C1 Inactivator Proteins | 1 | 2004 | 93 | 0.060 |
Why?
|
Anal Canal | 1 | 2007 | 376 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2019 | 4245 | 0.060 |
Why?
|
Surgical Instruments | 1 | 2007 | 395 | 0.060 |
Why?
|
Casein Kinase II | 1 | 2004 | 128 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4751 | 0.060 |
Why?
|
Pilot Projects | 1 | 2017 | 8324 | 0.060 |
Why?
|
Reoperation | 2 | 2012 | 4201 | 0.060 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2006 | 286 | 0.060 |
Why?
|
Hematoma | 1 | 2009 | 758 | 0.060 |
Why?
|
Adrenocortical Carcinoma | 1 | 2004 | 88 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3589 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2020 | 57776 | 0.060 |
Why?
|
Anastomosis, Surgical | 1 | 2007 | 987 | 0.060 |
Why?
|
Lung Diseases, Interstitial | 1 | 2012 | 808 | 0.060 |
Why?
|
Animals | 10 | 2020 | 168757 | 0.060 |
Why?
|
Elbow | 1 | 2004 | 138 | 0.060 |
Why?
|
Developing Countries | 1 | 2016 | 2815 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 697 | 0.060 |
Why?
|
New Zealand | 1 | 2004 | 355 | 0.060 |
Why?
|
Ulna | 1 | 2004 | 133 | 0.060 |
Why?
|
Laryngeal Neoplasms | 1 | 2007 | 512 | 0.060 |
Why?
|
Neoplasm Proteins | 2 | 2006 | 3703 | 0.060 |
Why?
|
Apoptosis | 3 | 2009 | 9727 | 0.060 |
Why?
|
Serpins | 1 | 2004 | 247 | 0.060 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2004 | 162 | 0.060 |
Why?
|
Heparin | 1 | 2010 | 1637 | 0.050 |
Why?
|
Risk Assessment | 5 | 2017 | 23338 | 0.050 |
Why?
|
Head and Neck Neoplasms | 3 | 2008 | 2734 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 3 | 2010 | 4554 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1294 | 0.050 |
Why?
|
Adrenal Glands | 1 | 2004 | 546 | 0.050 |
Why?
|
Pain | 1 | 2017 | 4986 | 0.050 |
Why?
|
Wound Infection | 1 | 2004 | 242 | 0.050 |
Why?
|
Forearm | 1 | 2004 | 409 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4204 | 0.050 |
Why?
|
Critical Illness | 1 | 2014 | 2670 | 0.050 |
Why?
|
Family Practice | 1 | 2004 | 516 | 0.050 |
Why?
|
Hypertension, Pulmonary | 1 | 2012 | 1537 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2005 | 2715 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2022 | 291 | 0.050 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3022 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2008 | 1741 | 0.050 |
Why?
|
Infant | 5 | 2013 | 35136 | 0.050 |
Why?
|
Up-Regulation | 2 | 2012 | 4217 | 0.050 |
Why?
|
Mammaplasty | 1 | 2010 | 1204 | 0.050 |
Why?
|
Phototherapy | 1 | 2023 | 377 | 0.050 |
Why?
|
Circadian Rhythm | 1 | 2012 | 2624 | 0.050 |
Why?
|
Pneumonectomy | 1 | 2007 | 1094 | 0.050 |
Why?
|
Oxygen | 1 | 2012 | 4189 | 0.050 |
Why?
|
Histocompatibility Testing | 2 | 2019 | 741 | 0.050 |
Why?
|
Immunoenzyme Techniques | 3 | 2010 | 1799 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2008 | 4851 | 0.040 |
Why?
|
Prospective Studies | 3 | 2021 | 53288 | 0.040 |
Why?
|
Biological Products | 1 | 2009 | 860 | 0.040 |
Why?
|
Privacy | 1 | 2022 | 239 | 0.040 |
Why?
|
Adolescent | 7 | 2019 | 85781 | 0.040 |
Why?
|
Chronic Disease | 1 | 2014 | 9146 | 0.040 |
Why?
|
Goats | 1 | 2019 | 171 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2022 | 20822 | 0.040 |
Why?
|
Cohort Studies | 3 | 2016 | 40561 | 0.040 |
Why?
|
Collagen | 1 | 2007 | 2689 | 0.040 |
Why?
|
Gels | 1 | 2019 | 427 | 0.040 |
Why?
|
Prevalence | 3 | 2023 | 15226 | 0.040 |
Why?
|
Focus Groups | 1 | 2023 | 1321 | 0.040 |
Why?
|
Antigens, Viral | 1 | 2022 | 1035 | 0.040 |
Why?
|
Alginates | 1 | 2019 | 252 | 0.040 |
Why?
|
Phospholipids | 1 | 2021 | 784 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20129 | 0.040 |
Why?
|
Survival Analysis | 3 | 2004 | 10252 | 0.040 |
Why?
|
Neuromuscular Junction | 1 | 2019 | 398 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2020 | 936 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1041 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7659 | 0.040 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 1988 | 0.040 |
Why?
|
Reference Standards | 1 | 2020 | 1025 | 0.030 |
Why?
|
ROC Curve | 2 | 2019 | 3527 | 0.030 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15076 | 0.030 |
Why?
|
Educational Status | 1 | 2004 | 2540 | 0.030 |
Why?
|
Parietal Bone | 1 | 2015 | 47 | 0.030 |
Why?
|
Biopsy | 1 | 2008 | 6756 | 0.030 |
Why?
|
Frontal Sinus | 1 | 2015 | 50 | 0.030 |
Why?
|
Risk Factors | 3 | 2017 | 72290 | 0.030 |
Why?
|
Frontal Bone | 1 | 2015 | 105 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2021 | 1284 | 0.030 |
Why?
|
Blotting, Western | 3 | 2010 | 5179 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3401 | 0.030 |
Why?
|
Colitis, Ulcerative | 1 | 2007 | 1912 | 0.030 |
Why?
|
Carcinoma | 1 | 2006 | 2375 | 0.030 |
Why?
|
Electrodes, Implanted | 1 | 2019 | 824 | 0.030 |
Why?
|
Child | 6 | 2012 | 77709 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19905 | 0.030 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2015 | 295 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2010 | 2915 | 0.030 |
Why?
|
Histocompatibility Antigens | 1 | 1975 | 471 | 0.030 |
Why?
|
Gene Expression | 2 | 2023 | 7799 | 0.030 |
Why?
|
Mastectomy | 1 | 2022 | 1793 | 0.030 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2015 | 234 | 0.030 |
Why?
|
Internship and Residency | 1 | 2014 | 5788 | 0.030 |
Why?
|
Vascular Grafting | 1 | 2015 | 142 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2015 | 492 | 0.030 |
Why?
|
Pan troglodytes | 1 | 2013 | 229 | 0.030 |
Why?
|
Sex Factors | 3 | 2004 | 10397 | 0.030 |
Why?
|
Mycophenolic Acid | 1 | 2015 | 343 | 0.030 |
Why?
|
Bites and Stings | 1 | 2013 | 91 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8388 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2008 | 9239 | 0.030 |
Why?
|
Factor XII Deficiency | 1 | 1992 | 4 | 0.030 |
Why?
|
Fascia Lata | 1 | 2012 | 15 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2690 | 0.030 |
Why?
|
Factor XI Deficiency | 1 | 1992 | 18 | 0.030 |
Why?
|
Sampling Studies | 1 | 2013 | 623 | 0.030 |
Why?
|
London | 1 | 2012 | 233 | 0.030 |
Why?
|
Autoimmunity | 1 | 2019 | 1349 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 2013 | 499 | 0.030 |
Why?
|
Brain Neoplasms | 2 | 2010 | 8863 | 0.030 |
Why?
|
Cell Membrane | 1 | 2021 | 3748 | 0.020 |
Why?
|
Tacrolimus | 1 | 2015 | 743 | 0.020 |
Why?
|
Noonan Syndrome | 1 | 1992 | 122 | 0.020 |
Why?
|
Cell Line, Tumor | 4 | 2009 | 16689 | 0.020 |
Why?
|
Child, Preschool | 5 | 2008 | 41006 | 0.020 |
Why?
|
Bile Duct Neoplasms | 1 | 2015 | 567 | 0.020 |
Why?
|
Cholangiocarcinoma | 1 | 2015 | 516 | 0.020 |
Why?
|
Pain Measurement | 1 | 2020 | 3420 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3218 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5524 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2013 | 1014 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 4479 | 0.020 |
Why?
|
Genes, Lethal | 1 | 2010 | 242 | 0.020 |
Why?
|
Phenotype | 2 | 2004 | 16365 | 0.020 |
Why?
|
Neuroendocrine Tumors | 1 | 2015 | 594 | 0.020 |
Why?
|
Body Constitution | 1 | 1990 | 278 | 0.020 |
Why?
|
Donor Selection | 1 | 2011 | 201 | 0.020 |
Why?
|
Cell Cycle | 2 | 2009 | 2967 | 0.020 |
Why?
|
Glucose Transporter Type 3 | 1 | 2009 | 16 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2010 | 251 | 0.020 |
Why?
|
Femoral Vein | 1 | 1990 | 159 | 0.020 |
Why?
|
Forecasting | 1 | 2018 | 2951 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4297 | 0.020 |
Why?
|
Proteins | 3 | 2010 | 6103 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 1974 | 719 | 0.020 |
Why?
|
Jugular Veins | 1 | 1990 | 204 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6933 | 0.020 |
Why?
|
Transcription Factor AP-2 | 1 | 2008 | 82 | 0.020 |
Why?
|
Oximetry | 1 | 2012 | 471 | 0.020 |
Why?
|
Hemophilia A | 1 | 1992 | 351 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15540 | 0.020 |
Why?
|
Proprotein Convertases | 1 | 2009 | 95 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2013 | 1240 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2007 | 3616 | 0.020 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2008 | 220 | 0.020 |
Why?
|
Spectroscopy, Fourier Transform Infrared | 1 | 2008 | 164 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1616 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2019 | 21827 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2453 | 0.020 |
Why?
|
Garlic | 1 | 2006 | 29 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2010 | 705 | 0.020 |
Why?
|
Mice | 5 | 2019 | 81183 | 0.020 |
Why?
|
Alkaloids | 1 | 2008 | 190 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2007 | 6895 | 0.020 |
Why?
|
Lower Extremity | 1 | 2014 | 1158 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15997 | 0.020 |
Why?
|
Preoperative Care | 1 | 2015 | 2250 | 0.020 |
Why?
|
Genes, p53 | 1 | 2008 | 755 | 0.020 |
Why?
|
Incidence | 1 | 2004 | 20947 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2006 | 323 | 0.020 |
Why?
|
Foot | 1 | 2009 | 527 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13695 | 0.020 |
Why?
|
Spectrometry, Fluorescence | 1 | 2008 | 689 | 0.020 |
Why?
|
S Phase | 1 | 2006 | 423 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2006 | 2942 | 0.020 |
Why?
|
Carotid Arteries | 1 | 1990 | 952 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 489 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 677 | 0.020 |
Why?
|
Signal Transduction | 2 | 2006 | 23403 | 0.020 |
Why?
|
Life Tables | 1 | 2004 | 370 | 0.020 |
Why?
|
Algorithms | 1 | 2005 | 13881 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2010 | 1142 | 0.020 |
Why?
|
Exercise Test | 1 | 2012 | 2074 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2004 | 190 | 0.010 |
Why?
|
Complement C1 Inhibitor Protein | 1 | 2004 | 97 | 0.010 |
Why?
|
Depression | 1 | 2023 | 7766 | 0.010 |
Why?
|
Microarray Analysis | 1 | 2007 | 767 | 0.010 |
Why?
|
Serine Endopeptidases | 1 | 2009 | 1072 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2004 | 1375 | 0.010 |
Why?
|
DNA Primers | 1 | 2007 | 2892 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2006 | 2085 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2007 | 1770 | 0.010 |
Why?
|
Patient Care Team | 1 | 2013 | 2531 | 0.010 |
Why?
|
Hedgehog Proteins | 1 | 2006 | 783 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8089 | 0.010 |
Why?
|
Bronchoscopy | 1 | 2007 | 862 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8642 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2007 | 2886 | 0.010 |
Why?
|
International Cooperation | 1 | 2007 | 1420 | 0.010 |
Why?
|
Protein Subunits | 1 | 2004 | 959 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2006 | 4320 | 0.010 |
Why?
|
Electrocardiography | 1 | 1974 | 6442 | 0.010 |
Why?
|
Kinetics | 1 | 2008 | 6473 | 0.010 |
Why?
|
Mice, Nude | 1 | 2006 | 3689 | 0.010 |
Why?
|
Hemorrhage | 1 | 1992 | 3461 | 0.010 |
Why?
|
Echocardiography | 1 | 2012 | 5102 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3479 | 0.010 |
Why?
|
Patient Selection | 1 | 2011 | 4215 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5974 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 2007 | 6364 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2015 | 5256 | 0.010 |
Why?
|
Transcription Factors | 2 | 2009 | 12208 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2004 | 1813 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 3772 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2010 | 9734 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6386 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12354 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2006 | 3505 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2008 | 8301 | 0.010 |
Why?
|
Cell Survival | 1 | 2006 | 5882 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 7023 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8436 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2010 | 14557 | 0.010 |
Why?
|
Hypertension | 1 | 1975 | 8480 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 13033 | 0.010 |
Why?
|
Methods | 1 | 1974 | 1129 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2010 | 11483 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9648 | 0.010 |
Why?
|
Rats | 1 | 2008 | 24260 | 0.010 |
Why?
|
Partial Thromboplastin Time | 1 | 1992 | 206 | 0.010 |
Why?
|
Neurons | 1 | 2010 | 9338 | 0.010 |
Why?
|
Body Surface Area | 1 | 1990 | 198 | 0.010 |
Why?
|
Disease Progression | 1 | 2004 | 13284 | 0.000 |
Why?
|
Smoking | 1 | 2004 | 8987 | 0.000 |
Why?
|
Age Factors | 2 | 1990 | 18370 | 0.000 |
Why?
|
Body Height | 1 | 1990 | 1577 | 0.000 |
Why?
|
Heart Rate | 1 | 1974 | 4091 | 0.000 |
Why?
|
Family | 1 | 1992 | 3147 | 0.000 |
Why?
|
Heart | 1 | 1974 | 4467 | 0.000 |
Why?
|
Body Weight | 1 | 1990 | 4669 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1974 | 11727 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1992 | 25625 | 0.000 |
Why?
|